[Wolfdev-Momentum] Exciting Brand New Pharmaceutical Company
Stock Report
sr@e-mrktng.net
Fri, 24 Sep 2004 01:01:46 -0700
This is a multi-part message in MIME format
--=_NextPart_2rfkindysadvnqw3nerasdf
Content-Type: text/html
Content-Transfer-Encoding: 7bit
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"
"http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>Untitled Document</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
</head>
<body>
<p align="center"><font face="Arial, Helvetica, sans-serif"><strong><font color="#FF0000" size="6">Stock Alert</font><font size="6"><br>
<font color="#FF0000">Company Profile :</font></font> <font size="6"><u><font color="#0000FF"><a href='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E400E404140464645400E08.aspx'>ATKJ.PK</a></font></u></font><br>
<a href='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E400E404140464645400E08.aspx'><font size="5">www.arpharmaceutical.net</font></a></strong></font><font size="5" face="Arial, Helvetica, sans-serif"><strong> </strong></font> </p>
<p align="center"><font face="Arial, Helvetica, sans-serif"><strong><font size="5">EXCITING BRAND NEW<br>
Pharmaceutical Company </font></strong></font></p>
<p align="center"><font face="Arial, Helvetica, sans-serif"><strong><font color="#0000FF"><a href='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E400E404140464645400E08.aspx'>ATKJ.PK HAS A LIMITED # of SHARES Available – This WILL MOVE QUICKLY<br>
</a></font></strong></font><a href='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E400E404140464645400E08.aspx'><font color="#0000FF" face="Arial, Helvetica, sans-serif"><strong>Recommendation: STRONG BUY</strong></font></a></p>
<p align="center"><font size="2" face="Arial, Helvetica, sans-serif">What if a company had a New Cancer Treatment product that had No Side Effects and had been used<br>
successfully overseas to combat several of the major forms of Cancer???</font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif"><strong>We are bringing ATKJ.PK to your attention and on its first day of trading it will<br>
EXPLODE! (Monday Sept. 20 th ) <br>
</strong></font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif"><strong>ARTEC Inc. (OTC Ticker: ATKJ or ATKJ.PK) <br>
</strong>Current Price: $1.80 <br>
Near Term Target: $ <strong>5.50<br>
</strong></font><font size="2" face="Arial, Helvetica, sans-serif">6-12 Month Projection: $ <strong>9.00+</strong></font><font size="2" face="Arial, Helvetica, sans-serif"><strong> </strong></font></p>
<p align="center"><font size="2" face="Arial, Helvetica, sans-serif">Past Pharmaceutical Companies have taken 1 product and almost overnight have developed into<br>
100+ Million Dollar a year Giants</font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif"><strong>Company Profile</strong></font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">Artec, Inc. is a Pharmaceutical Company incorporated in Nevada , whose primary focus is to obtain FDA approval for its amazing new product called Tubercin. Tubercin is an internationally patented pharmaceutical product used in the treatment of cancer. Tubercin is patented in the United States registration # 6,274,356, Canada , United Kingdom , France , Spain , Germany , Italy , South Korea and Japan . </font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">Tubercin is supported by over 17 years of clinical treatment in an international accredited hospital setting. Over 2000 patients have been treated overseas using Tubercin under strict clinical settings. </font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">Tubercin was developed by Dr. Tai Ho Chung, Ph.D. the former Medical School Dean of the oldest and most prestigious hospital in South Korea , Kyungpook National Medical School . Dr. Chung is currently the Director of the medical research center overseeing research on hepatitis for the World Health Organization. Dr. Chung is also the inventor, principal partner and scientific advisor for Artec Inc. </font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif"><strong>Market Potential</strong></font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">A new federal study says that health care costs will double in the next nine years and prescription-drug costs will almost triple. U.S. pharmaceutical sales were $220 billion in 2002 and worldwide drug sales reached $430 billion. It is difficult to estimate the cancer drug market however one effective drug could have a market value of from $200 million to $1 billion plus per year to treat only one to two kinds of cancer. Given that Tubercin has been used to treat stomach, lung, rectal, esophageal, breast, pancreatic, lymphoma, colon and melanoma among others the market for Tubercin could be interpolated to be in excess of $1 billion per year in the U.S. alone and $2 billion worldwide.</font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">An additional market for Tubercin is the animal market. Cancer is the number one natural cause of death in geriatric cats and dogs, and it accounts for nearly 50 percent of pet deaths each year. Therapeutic modalities for veterinary cancer patients are similar to those available to humans, including surgery, chemotherapy, radiation therapy, and biotherapy. It has been estimated that there are 42 million dogs and approximately 20 million cats in the United States . We feel these numbers support an enormous secondary growth area for the use of Tubercin.</font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">ATKJ.PK a strong addition to your portfolio.</font></p>
<p><font size="2" face="Arial, Helvetica, sans-serif">Recommendation: STRONG BUY<br>
</font><font size="2" face="Arial, Helvetica, sans-serif">Symbol: ATKJ.PK (Artec Inc.)</font><font size="2" face="Arial, Helvetica, sans-serif"><strong> </strong></font></p>
<p align="LEFT"><font size="1" face="Arial, Helvetica, sans-serif">Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will", "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks,securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. We have been paid 20,000 dollars for this mailing from a third party.</font></p>
<font size="1" face="Arial, Helvetica, sans-serif"><strong>Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions goals expectations beliefs plans projections objectives assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." </strong></font>
<br><br><table width='500' border='0' align='center' cellpadding='2' cellspacing='3'><tr><td align='center'> <p align='center'>
<div align='center'><a href='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E08.aspx'><img src='http://www.infoemail-web.com/img.gif' width='531' height='80' border='0'></a>
<font size='1' face='Arial, Helvetica, sans-serif'><br><img src='http://www.infoemail-web.com/080E051D1E141617043206051D5C02131B001E1B01065C1C17060E4145444B450E470E430E420E08.aspx'>
</font><font color="#999999" face="arial, verdana" size="2">Artec, Inc. · 5960 S. Land Park Drive, #255 · Sacrament, CA 95822</font></p></td></tr></table></body>
</html>
--=_NextPart_2rfkindysadvnqw3nerasdf--